
Get exclusive money-saving offers and guides
Straight to your inbox
Posted
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
AFT Pharmaceuticals Limited is a drug manufacturers—specialty & generic business based in Australia. AFT Pharmaceuticals shares (AFP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. and has a market cap (total outstanding shares value) of $479.3 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, AFT Pharmaceuticals's share price has had significant positive movement.
Its last market close was $4.71, which is 34.18% up on its pre-crash value of $3.1 and 51.94% up on the lowest point reached during the March crash when the shares fell as low as $3.1.
If you had bought $1,000 worth of AFT Pharmaceuticals shares at the start of February 2020, those shares would have been worth $1,129.03 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,519.35.
52-week range | $2.66 - $5.05 |
---|---|
50-day moving average | $4.6939 |
200-day moving average | $4.2235 |
Target price | N/A |
PE ratio | 38.6033 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $0.1175 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$4.71 on 2020-10-22
1 week (2021-01-11) | -4.46% |
---|---|
1 month (2020-12-18) | 14.04% |
3 months (2020-10-16) | 0.43% |
6 months (2020-07-17) | 15.16% |
1 year (2020-01-17) | 51.94% |
---|---|
2 years (2019-01-18) | 138.48% |
3 years (2018-01-18) | 124.29% |
5 years (2016-01-18) | 68.21% |
Valuing AFT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AFT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AFT Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, AFT Pharmaceuticals shares trade at around 39x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Gross profit TTM | $48.3 million |
---|---|
Return on assets TTM | 9.54% |
Return on equity TTM | 113.6% |
Profit margin | 12.02% |
Book value | N/A |
Market capitalisation | $479.3 million |
TTM: trailing 12 months
We're not expecting AFT Pharmaceuticals to pay a dividend over the next 12 months.
Over the last 12 months, AFT Pharmaceuticals's shares have ranged in value from as little as $2.66 up to $5.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while AFT Pharmaceuticals's is 0.4146. This would suggest that AFT Pharmaceuticals's shares are less volatile than average (for this exchange).
AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.